Welcome to the world of advanced antibiotic therapy with Cephradine, a trusted and potent medication designed to combat bacterial infections effectively. With its broad spectrum of action and proven track record, Cephradine stands as a reliable choice for healthcare providers and patients alike. Embrace the power of Cephradine to restore health and vitality in the face of bacterial challenges.
What is Cephradine?
Cephradine belongs to the class of first-generation cephalosporin antibiotics. It is formulated to target a wide range of bacterial pathogens responsible for various infections. As a beta-lactam antibiotic, Cephradine disrupts bacterial cell wall synthesis, leading to the eventual death of the harmful bacteria.
How Does Cephradine Work?
Cephradine's mode of action involves inhibiting the enzymes responsible for building bacterial cell walls. By doing so, it weakens the integrity of the cell wall, causing it to rupture and leading to the destruction of the bacteria. This mechanism ensures a rapid and effective response to bacterial infections.
Key Features and Benefits:
1:Broad-Spectrum Activity: Cephradine showcases excellent efficacy against both Gram-positive and Gram-negative bacteria, making it a versatile solution for a wide range of infections.
2:Respiratory Infections: Cephradine is particularly effective in treating respiratory infections, including bronchitis, tonsillitis, and sinusitis, offering relief from troublesome symptoms.
3:Urinary Tract Infections (UTIs): Cephradine helps combat UTIs caused by susceptible bacteria, promoting quick recovery and reducing the risk of complications.
4:Skin and Soft Tissue Infections: From mild to moderate skin infections, Cephradine targets bacteria responsible for cellulitis, wound infections, and other skin-related concerns.
5:Surgical Prophylaxis: Cephradine is widely used as a prophylactic measure before certain surgical procedures to prevent potential infections.
|
Product Name:
|
Cefradine
|
|
Batch No:
|
32051704082
|
Manuf Date:
|
20 April 2017
|
|
LAB Record No.
|
BPAC04-1704005
|
Specification:
|
BP2014
|
|
Package Size:
|
25kg/drum
|
Batch Size:
|
857.21Kg
|
|
Report Date
|
03 May 2017
|
Retest Date:
|
March 2020
|
|
PARAMETER
|
SPECIFICATIONS
|
RESULTS
|
|
Anpearance
|
white or slightly yellow,
hygroscopic powder
|
Complies
|
|
Identification
|
The IR spectrum confirm to
that of reference standard
|
Complies
|
|
Appearance of solution
|
less opalescent than
reference suspension II
|
<reference suspension I
|
|
The absorbance at 450 nm
is not greater than 0.60
|
0.02
|
|
pH
|
3.5~6.0
|
5.1
|
|
Specific optical rotation
|
+80.0°~+90.0°
|
+84.9°
|
|
Related substances
|
(D-dihydrophenylgcine
NMT 0.25%)
|
0.01%
|
|
(Impurity A NMT 0.25%)
|
N.D.
|
|
(Impurity C NMT 0.25%)
|
0.04%
|
|
Cmpurity D NMT 0.25%)
|
0.05%
|
|
(Impurity E NMT 0.25%)
|
0.03%
|
|
(Impurity F NMT 0.25%)
|
N.D.
|
|
(Impurity G NMT 0.25%)
|
N.D.
|
|
(Any other impurity NMT 0.25%)
|
0.08%
|
|
(Total impurities NMT 2.0%)
|
0.38%
|
|
N,N-Dimethylformamide
|
NMT 0.088%
|
N.D.
|
|
Acetone
|
NMT 0.5%
|
0.008%
|
|
Methylene chloride
|
NMT 0.06%
|
0.009%
|
|
Water Content
|
NMT 6.0%
|
4.1%
|
|
Sulfated ash
|
NMT 0.2%
|
<0.1%
|
|
Assay
|
cefradine : minimum 90.0 per cent
(anhydrous substance)
|
97.8%
|
|
cefalexin: maximum 5.0 per cent
(anhydrous substance)
|
1.2%
|
|
4'.5-dihydrocefradine: maximum
2.0 per cent(anhydrous substance)
|
0.8%
|
|
sum of the percentage contents of
cefradine, cefalexin and 4',5'-
dihydrocefradine :96.0 per cent
to 102.0 per cent(anhydrous
substance)
|
99.8%
|
|
Bulk Density
|
For Information only
|
0.60g/ml
|
|
Tapped Density
|
For Information only
|
0.87g/ml
|
|
Remarks:
|
N,N-Dimethylaniline in this process is not utilized 2 0 H
|
|
Conclusion
|
The product complies with specification BP2014.
|
|
Pharma Sources Insight June 2024: Globalization on the Go
